A review in Cell Biology and Toxicology reports that targeting core regulators of PANoptosis reduced tissue injury across multiple ischemic animal models. PANoptosis is described as a coordinated programmed cell-death mechanism integrating apoptosis, pyroptosis, and necroptosis. The authors emphasize shared hubs—such as CASP8, RIPK1, and ZBP1—that converge across the death pathways, implying that multi-modal blockade could outperform single-path interventions in ischemic damage. The review surveys organ-specific roles across cerebral, myocardial, renal, retinal, and limb ischemia scenarios. For translational planning, this positions PANoptosis intersection points as candidates for therapeutic exploration, particularly where ischemia triggers mixed death modalities and downstream amplification.
Get the Daily Brief